BGMD logo

BG Medicine, Inc. Stock Price

OTCPK:BGMD Community·US$11.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BGMD Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

BGMD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

BG Medicine, Inc. Key Details

US$1.6m

Revenue

US$505.0k

Cost of Revenue

US$1.1m

Gross Profit

US$8.0m

Other Expenses

-US$7.0m

Earnings

Last Reported Earnings
Dec 31, 2015
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About BGMD

Founded
2000
Employees
n/a
CEO
n/a
WebsiteView website
www.bg-medicine.com

BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was incorporated in 2000 and is headquartered in Waltham, Massachusetts.

Recent BGMD News & Updates

No updates

Recent updates

No updates